ISSFAL 2014 debate: It is time to update saturated fat recommendations

Annals of Nutrition and Metabolism

Volumn 66, Issue 2-3, 2015, Pages 104-108

  Nettleton, Joyce A ^a   Legrand, Philippe ^b   Mensink, Ronald P ^c  

^a ScienceVoice Consulting   (United States)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Dietary fat and coronary heart disease; Dietary recommendations; Saturated fatty acids

Indexed keywords

CARBOHYDRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; FAT INTAKE; FATTY ACID; UNSATURATED FATTY ACID;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY RISK; DIETARY INTAKE; FAT INTAKE; GLYCEMIC INDEX; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK REDUCTION; BLOOD; CORONARY ARTERY DISEASE; HEALTH CARE POLICY; HUMAN; RISK FACTOR; SWEDEN; TRENDS;

CHOLESTEROL, LDL; CORONARY DISEASE; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; NUTRITION POLICY; RISK FACTORS; SWEDEN;

EID: 84921896209     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000371585     Document Type: Conference Paper

References (68)

1. American Heart Association: Dietary fat and its relation to heart attacks and strokes. Report by the Central Committee for Medical and Community Program of the American Heart Association. JAMA 1961; 175: 389-391.
2. Keys A, Anderson JT, Grande F: Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet 1957; 273: 959-966.
3. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd: Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55: 33-50.
4. Ravnskov U: The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998; 51: 443-460.
5. Taubes G: Nutrition. The soft science of dietary fat. Science 2001; 291: 2536-2545.
6. Sanders TA: Reappraisal of SFA and cardiovascular risk. Proc Nutr Soc 2013; 72: 390-398.
7. Lawrence GD: Dietary fats and health: dietary recommendations in the context of scientific evidence. Adv Nutr 2013; 4: 294-302.
8. German JB, Dillard CJ: Saturated fats: what dietary intake? Am J Clin Nutr 2004; 80: 550-559.
9. Libby P: Changing concepts of atherogenesis. J Intern Med 2000; 247: 349-358.
10. Institute of Medicine: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC, The National Academies Press, 2010.
11. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91: 535-546.
12. Skeaff CM, Miller J: Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009; 55: 173-201.
13. Mensink RP: Effects of stearic acid on plasma lipid and lipoproteins in humans. Lipids 2005; 40: 1201-1205.
14. Stamler J: Diet-heart: a problematic revisit. Am J Clin Nutr 2010; 91: 497-499.
15. Pedersen JI, James PT, Brouwer IA, Clarke R, Elmadfa I, Katan MB, Kris-Etherton PM, Kromhout D, Margetts BM, Mensink RP, Norum KR, Rayner M, Uusitupa M: The importance of reducing SFA to limit CHD. Br J Nutr 2011; 106: 961-963.
16. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition: Interim Summary of Conclusions and Dietary Recommendations on Total Fat and Fatty Acids. Geneva, World Health Organization, 2008, pp 1-12.
17. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89: 1425-1432.
18. Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1000252.
19. Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M, Becker W: Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res 2014; 58: 25145.
20. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L: The role of shortchain fatty acids in health and disease. Adv Immunol 2014; 121: 91-119.
21. Towler DA, Gordon JI, Adams SP, Glaser L: The biology and enzymology of eukaryotic protein acylation. Annu Rev Biochem 1988; 57: 69-99.
22. Hughes TA, Heimberg M, Wang X, Wilcox H, Hughes SM, Tolley EA, Desiderio DM, Dalton JT: Comparative lipoprotein metabolism of myristate, palmitate, and stearate in normolipidemic men. Metabolism 1996; 45: 1108-1118.
23. Legrand P, Rioux V: The complex and important cellular and metabolic functions of saturated fatty acids. Lipids 2010; 45: 941-946.
24. Shadid S, Koutsari C, Jensen MD: Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes 2007; 56: 1369-1375.
25. Rhee SK, Kayani AJ, Ciszek A, Brenna JT: Desaturation and interconversion of dietary stearic and palmitic acids in human plasma and lipoproteins. Am J Clin Nutr 1997; 65: 451-458.
26. Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH, Liu K: Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol 2012; 302:G1405-G1415.
27. Hofmanova J, Strakova N, Vaculova AH, Tylichova Z, Safarikova B, Skender B, Kozubik A: Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer. Mediators Inflamm 2014; 2014: 848632.
28. Yamagishi K, Nettleton JA, Folsom AR; ARIC Study Investigators: Plasma fatty acid composition and incident heart failure in middleaged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 965-974.
29. Lemaitre RN, King IB, Sotoodehnia N, Knopp RH, Mozaffarian D, McKnight B, Rea TD, Rice K, Friedlander Y, Lumley TS, Raghunathan TE, Copass MK, Siscovick DS: Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010; 59: 1029-1034.
30. Kabagambe EK, Baylin A, Siles X, Campos H: Individual saturated fatty acids and nonfatal acute myocardial infarction in Costa Rica. Eur J Clin Nutr 2003; 57: 1447-1457.
31. Legrand P, Morise A, Kalonji E: Update of French Nutritional Recommendations for Fatty Acids; in Simopoulos AP (ed): Healthy Agriculture, Healthy Nutrition, Healthy People. Basel, Karger, 2011, pp 137-143.
32. Kinosian B, Glick H, Preiss L, Puder KL: Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med 1995; 43: 443-450.
33. Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
34. Mente A, de Koning L, Shannon HS, Anand SS: A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169: 659-669.
35. Micha R, Mozaffarian D: Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010; 45: 893-905.
36. Faghihnia N, Mangravite LM, Chiu S, Bergeron N, Krauss RM: Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men. Eur J Clin Nutr 2012; 66: 1229-1233.
37. Mensink RP: Dietary Fatty acids and cardiovascular health - an ongoing controversy. Ann Nutr Metab 2011; 58: 66-67.
38. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B: Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 2003; 25: 50-57.
39. Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, Jakobsen MU, Kok FJ, Krauss RM, Lecerf JM, LeGrand P, Nestel P, Riserus U, Sanders T, Sinclair A, Stender S, Tholstrup T, Willett WC: The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 2011; 93: 684-688.
40. Sonestedt E, Wirfalt E, Wallstrom P, Gullberg B, Drake I, Hlebowicz J, Nordin Fredrikson G, Hedblad B, Nilsson J, Krauss RM, Orho-Melander M: High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr 2012; 107: 1062-1069.
41. Jakobsen MU, Dethlefsen C, Joensen AM, Stegger J, Tjonneland A, Schmidt EB, Overvad K: Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010; 91: 1764-1768.
42. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA, PREDIMED Study Investigators: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279-1290.
43. Jakobsen MU, Overvad K: Macronutrient advice for ischemic heart disease prevention. Curr Opin Lipidol 2011; 22: 33-36.
44. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM: Lowfat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 655-666.
45. Parks EJ, Parks EJ: Changes in fat synthesis influenced by dietary macronutrient content. Proc Nutr Soc 2002; 61: 281-286.
46. Siri PW, Krauss RM: Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 2005; 7: 455-459.
47. Gerber PA, Berneis K: Regulation of low-density lipoprotein subfractions by carbohydrates. Curr Opin Clin Nutr Metab Care 2012; 15: 381-385.
48. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM: Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2014; 34: 1069-1077.
49. Krauss RM, Dreon DM: Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995; 62: 478S-487S.
50. Dreon DM, Fernstrom HA, Miller B, Krauss RM: Low-density lipoprotein subclass patterns and lipoprotein response to a reducedfat diet in men. FASEB J 1994; 8: 121-126.
51. Dayton S, Pearce ML, Goldman H, Harnish A, Plotkin D, Shickman M, Winfield M, Zager A, Dixon W: Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet 1968; 2: 1060-1062.
52. Leren P: The Oslo diet-heart study. Elevenyear report. Circulation 1970; 42: 935-942.
53. Frantz ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER: Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis 1989; 9: 129-135.
54. Morris JN, Ball K, Antonis A: Controlled trial of soya-bean oil in myocardial infarction. Report of a research committee to the Medical Research Council. Lancet 1968; 2: 693-700.
55. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM: n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010; 104: 1586-1600.
56. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR: Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013; 346:e8707.
57. Swain JF, McCarron PB, Hamilton EF, Sacks FM, Appel LJ: Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (Omni-Heart): options for a heart-healthy diet. J Am Diet Assoc 2008; 108: 257-265.
58. Bertoia ML, Triche EW, Michaud DS, Baylin A, Hogan JW, Neuhouser ML, Tinker LF, Van Horn L, Waring ME, Li W, Shikany JM, Eaton CB: Mediterranean and Dietary Approaches to Stop Hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am J Clin Nutr 2014; 99: 344-351.
59. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ; American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2960-2984.
60. Stradling C, Hamid M, Taheri S, Thomas GN: A review of dietary influences on cardiovascular health: part 2: dietary patterns. Cardiovasc Hematol Disord Drug Targets 2014; 14: 50-63.
61. de Lorgeril M, Salen P: Mediterranean diet in secondary prevention of CHD. Public Health Nutr 2011; 14: 2333-2337.
62. Chiva-Blanch G, Badimon L, Estruch R: Latest evidence of the effects of the Mediterranean diet in prevention of cardiovascular disease. Curr Atheroscler Rep 2014; 16: 446.
63. Lands B: Historical perspectives on the impact of n-3 and n-6 nutrients on health. Prog Lipid Res 2014; 55: 17-29.
64. Nettleton JA, Jebb S, Riserus U, Koletzko B, Fleming J: Role of dietary fats in the prevention and treatment of the metabolic syndrome. Ann Nutr Metab 2014; 64: 167-178.
65. Waddington E, Sienuarine K, Puddey I, Croft K: Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal Biochem 2001; 292: 234-244.
66. World Life Expectancy: World Health Rankings: Coronary Heart Disease, Age Standardized Death Rates; in Anonymous (ed): World Health Rankings, World Life Expectancy, 2011.
67. Amarasiri WA, Dissanayake AS: Coconut fats. Ceylon Med J 2006; 51: 47-51.
68. Voon PT, Ng TK, Lee VK, Nesaretnam K: Diets high in palmitic acid (16: 0), lauric and myristic acids (12: 0 + 14: 0), or oleic acid (18: 1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr 2011; 94: 1451-1457.